Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Altimmune Names Jerry Durso Chairman As Company Prepares For Phase 3 Development Of Pemvidutide In MASH

Author: Benzinga Newsdesk | August 11, 2025 06:37am

Appointment recognizes Mr. Durso's extensive commercial expertise as Altimmune prepares for Phase 3 development of pemvidutide in MASH
Mitchel Sayare, Ph.D., to remain on the Board as Independent Director

Posted In: ALT